SEC Form 4 · accession 0000921895-18-002461
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dimitrios Angelis
Director
Period of report
Aug 20, 2018
Accepted (ET)
Aug 22, 2018 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 40,990 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy)F1 | $1.53 | Aug 20, 2018 | A | 35,000 | A | — | — | Common Stock | 35,000 | 35,000 | D |
| Restricted Stock UnitF2,F3 | — | Aug 20, 2018 | A | 10,000 | A | — | — | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The options vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders of the Issuer occurring after August 16, 2018. The options will expire on the fifth anniversary of the vesting date.
- F2Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
- F3The Restricted Stock Units vest on the first anniversary of the grant date.